Open AccessPost-Kala-Azar Dermal Leishmaniasis in a Patient Treated with Injectable Paromomycin for Visceral Leishmaniasis in India
Author(s) -
Krishna Pandey,
Vidya Nand Rabi Das,
Dharmendra Singh,
Sushmita Das,
Chandra Shekhar Lal,
Neena Verma,
Sanjiva Bimal,
Roshan Kamal Topno,
Nasir A. Siddiqui,
Rakesh Bihari Verma,
Prabhat Kumar Sinha,
Pradeep Das
Publication year - 2012
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.05966-11
Subject(s) - paromomycin , visceral leishmaniasis , leishmaniasis , medicine , dermatology , leishmania donovani , protozoal disease , immunology , antibiotics , biology , microbiology and biotechnology , malaria , aminoglycoside
Post kala-azar dermal leishmaniasis (PKDL) is a skin manifestation that usually develops after treatment of visceral leishmaniasis (VL), a major public health problem in India. The diagnosis and management of PKDL is complex. This is the first case report from India in which PKDL occurred after paromomycin treatment for VL in an Indian patient.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom